Stockscreener 앱 받기
117.36
1.26%
1.46
시간 외 거래:
117.42
0.06
+0.05%
전일 마감가:
$115.90
열려 있는:
$115.575
하루 거래량:
4.82M
Relative Volume:
1.07
시가총액:
$202.64B
수익:
$41.22B
순이익/손실:
$5.77B
주가수익비율:
39.92
EPS:
2.94
순현금흐름:
$6.49B
1주 성능:
+0.48%
1개월 성능:
-1.70%
6개월 성능:
+12.75%
1년 성능:
+17.89%
1일 변동 폭
$115.51
$117.94
1주일 범위
$114.43
$117.94
52주 변동 폭
$98.95
$121.64
애보트 래버러토리스 Stock (ABT) Company Profile
명칭
Abbott Laboratories
전화
(224) 667-6100
주소
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
ABT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
애보트 래버러토리스 Stock (ABT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-08 | 개시 | Oppenheimer | Outperform |
| 2024-09-19 | 개시 | Piper Sandler | Overweight |
| 2024-07-30 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-21 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | 재확인 | Barclays | Overweight |
| 2023-04-20 | 재확인 | Bernstein | Outperform |
| 2023-04-20 | 재확인 | JP Morgan | Overweight |
| 2023-04-20 | 재확인 | Raymond James | Outperform |
| 2023-04-20 | 재확인 | UBS | Buy |
| 2023-04-20 | 재확인 | Wolfe Research | Underperform |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-10-26 | 개시 | Mizuho | Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-27 | 재확인 | Credit Suisse | Outperform |
| 2022-01-27 | 재확인 | Morgan Stanley | Overweight |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | UBS | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-10-27 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-01-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-06-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-02-07 | 재확인 | BofA/Merrill | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2018-11-30 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-01-30 | 재확인 | Citigroup | Neutral |
| 2018-01-25 | 재확인 | Stifel | Buy |
| 2018-01-25 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-10-19 | 재확인 | Stifel | Buy |
모두보기
애보트 래버러토리스 주식(ABT)의 최신 뉴스
Abbott opens new Kilkenny site for diabetes tech - SiliconRepublic.com
Mawer Investment Management Ltd. Sells 24,407 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Opens New Diabetes Care Mfg Facility in Ireland - MPO-mag
First Western Trust Bank Lowers Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott opens new FreeStyle Libre manufacturing plant in Ireland - Mass Device
MAI Capital Management Sells 9,904 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
US medtech firm Abbott creates 800 jobs in Kilkenny - Irish Independent
Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland - cnhinews.com
Vitamin D Testing Market Size to Reach USD 1774.70 Million by 2031 | SkyQuest Technology - Benzinga
Swiss National Bank Purchases 26,000 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
With 77% institutional ownership, Abbott Laboratories (NYSE:ABT) is a favorite amongst the big guns - Simply Wall St
Mizuho Securities USA LLC Has $12.86 Million Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Mutual of America Capital Management LLC Has $24.39 Million Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Mizuho Markets Americas LLC - MarketBeat
Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy Now - Insider Monkey
Natixis Advisors LLC Purchases 204,478 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Kentucky Retirement Systems Insurance Trust Fund Sells 4,596 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Kentucky Retirement Systems Has $13.82 Million Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Ipswich Investment Management Co. Inc. Cuts Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Miramar Capital LLC - MarketBeat
Abbott extends executive agreements through 2026 By Investing.com - Investing.com Nigeria
Abbott Laboratories (ABT) Extends Executive Change in Control Ag - GuruFocus.com
Abbott Inks $8M Deal With Healthcare Fraudster In TM Suit - Law360
Abbott Laboratories stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Abbott Laboratories (NYSE:ABT) Stock Position Increased by First Long Island Investors LLC - MarketBeat
Abbott Laboratories (NYSE:ABT) Stock Holdings Increased by Simplify Asset Management Inc. - MarketBeat
Vectors Research Management LLC Makes New Investment in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Holdings Raised by CIBC Asset Management Inc - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Dearborn Partners LLC - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Curi RMB Capital LLC - MarketBeat
Victory Capital Management Inc. Trims Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Entropy Technologies LP Has $611,000 Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Drug Device Combination Market Is Booming Worldwide | 3M, Abbott Laboratories, AlloSource, Biomet Orthopedics Inc - openPR
Judge Finds Dexcom Infringed Abbott Patent That Hung Jury - Law360
Abbott Laboratories stock outperforms competitors despite losses on the day - MarketWatch
Abbott Gets Damages Trial as Judge Adds to DexCom's Patent Woes - Bloomberg Law
Topics: Missouri Margo Gill v. Abbott Laboratories, et al. - CVN News
ING Groep NV Grows Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Sivik Global Healthcare LLC Takes $6.84 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Ferguson Wellman Capital Management Inc. - MarketBeat
Abbott Laboratories (NYSE:ABT) Stake Raised by KBC Group NV - MarketBeat
Versor Investments LP Acquires New Shares in Abbott Laboratories (NYSE:ABT) - MarketBeat
Los Angeles Capital Management LLC Sells 54,709 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Labs granted variances for fencing and buffer areas for new plant on north end of BG - BG Independent News
Abbott Laboratories stock underperforms Wednesday when compared to competitors - MarketWatch
Abbott Laboratories (NYSE:ABT) Shares Acquired by Schrum Private Wealth Management LLC - MarketBeat
Oppenheimer Asset Management Inc. Has $28.78 Million Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Saturna Capital Corp Cuts Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Stock Position Raised by Dillon & Associates Inc. - MarketBeat
Prime Capital Investment Advisors LLC Sells 26,308 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Invest with Confidence: Intrinsic Value Unveiled of Abbott Labor - GuruFocus.com
애보트 래버러토리스 (ABT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.17%
3.98%
자본화:
|
볼륨(24시간):